MCID: PLY018
MIFTS: 55

Polycythemia malady

Summaries for Polycythemia

Sources:
64Wikipedia, 33MalaCards
See all sources

Fully expand this MalaCard

Export this MalaCard
Wikipedia:64 Polycythemia (also known as polycythaemia or polyglobulia) is a disease state in which the proportion of... more...

MalaCards: Polycythemia, also known as polycythemia, nos, is related to polycythemia vera and primary polycythemia. An important gene associated with Polycythemia is CD177 (CD177 molecule), and among its related pathways are Akt Signaling and Jak-STAT signaling pathway. The compounds tyrosine and vegf have been mentioned in the context of this disorder. Related mouse phenotypes are hematopoietic system and immune system.

Aliases & Classifications for Polycythemia

Sources:
8Disease Ontology, 10DISEASES, 45Novoseek, 61UMLS, 35MeSH, 57SNOMED-CT, 40NCIt
See all sources

Aliases & Descriptions:

polycythemia 8 10 45 61
polycythemia, nos 8
erythrocythemia 8
polycythaemia 8


External Ids:

Disease Ontology8 DOID:8432
MeSH35 D011086
NCIt40 C26863

Related Diseases for Polycythemia

Sources:
17GeneCards, 18GeneDecks
See all sources

Diseases related to Polycythemia via text searches within MalaCards or GeneCards/GeneDecks gene sharing:

(show top 50)    (show all 296)
idRelated DiseaseScoreTop Affiliating Genes
1polycythemia vera31.8PF4, IL3, KITLG, THPO, ACP1, PTPN6
2primary polycythemia31.1VHL, JAK2, STAT5A, EPO, EPOR
3erythrocytosis30.7VHL, JAK2, MPL, CD177, EPO, EPOR
4thrombocytosis30.5IL3, KITLG, THPO, PF4, EPOR, EPO
5acquired polycythemia30.5JAK2, EPO, EPOR
6myeloproliferative disorder30.4IFNA2, G6PD, PPBP, JAK2, STAT5A, ITGB3
7acute leukemia30.3JAK2, STAT5A, MPL, PTPN6, ACP1, THPO
8chronic myeloid leukemia30.3PPBP, JAK2, STAT5A, ITGB3, MPL, CD177
9splenomegaly30.2IFNA2, JAK2, MPL, EPO, THPO
10thrombocytopenia30.2IFNA2, PPBP, ITGB3, MPL, EPO, PF4
11acute myocardial infarction29.9PPBP, PF4, KITLG
12thromboembolism29.9G6PD, PF4
13vascular disease29.9TIMP1, JAK2, PF4
14vasculitis29.9PPBP, IFNA2
15thalassemia29.9EPO, G6PD
16thrombophilia29.9PF4, PPBP
17antiphospholipid syndrome29.9PF4
18deficiency anemia29.7MPL, EPO, EPOR, IL3, KITLG, THPO
19adenocarcinoma29.7JAK2, SOCS3, VHL, TIMP1, STAT5A, EPOR
20refractory anemia29.7THPO, KITLG, IL3, JAK2, MPL, EPO
21atherosclerosis29.7TIMP1, SOCS3, G6PD, PPBP, ITGB3, PF4
22chronic myelomonocytic leukemia29.7JAK2, STAT5A, MPL, KITLG
23pancytopenia29.7THPO, IL3, EPO, MPL
24hepatitis c29.7TIMP1, IFNA2, SOCS3, THPO
25tuberculosis29.7ACP1, PF4
26portal vein thrombosis29.7THPO
27hemorrhagic thrombocythemia29.7CD177
28neurofibromatosis29.7VHL
29renal clear cell carcinoma29.7EPOR, VHL
30hypersplenism29.7THPO
31essential thrombocythemia10.9
32erythropoietin polycythemia10.7
33hypermanganesemia with dystonia polycythemia and cirrhosis10.5
34stress polycythemia10.4
35hypoxia10.3
36paraganglioma10.2
37acute myeloid leukemia10.2
38chronic neutrophilic leukemia10.2
39chorea10.2
40focal segmental glomerulosclerosis10.1
41splenic infarction10.1
42focal glomerulosclerosis10.1
43n syndrome10.1
44t-cell leukemia10.1
45twin twin transfusion syndrome10.1
46thrombocythemia 210.1
47erythrocytosis, somatic10.1
48dehydration polycythemia10.1
49hemochromatosis10.1
50physiological polycythemia10.1

Graphical network of the top 20 diseases related to Polycythemia:



Diseases related to polycythemia

Clinical Features for Polycythemia

Drugs & Therapeutics for Polycythemia

Sources:
5CenterWatch, 42NIH Clinical Center, 6ClinicalTrials, 61UMLS, 41NDF-RT
See all sources

Approved drugs:

Search CenterWatch for Polycythemia

Drug clinical trials:

Search ClinicalTrials for Polycythemia

Search NIH Clinical Center for Polycythemia

Search CenterWatch for Polycythemia

Genetic Tests for Polycythemia

Anatomical Context for Polycythemia

Animal Models for Polycythemia or affiliated genes

Sources:
37MGI, 28inGenious Targeting Laboratory
See all sources

Publications for Polycythemia

Sources:
51PubMed
See all sources

Articles related to Polycythemia:

(show top 50)    (show all 898)
idTitleAuthorsYear
1
IgG-lymphoplasmacytic lymphoma following polycythemia vera: JAK2 V617F and MYD88 L265P mutations separated in the same house. (24408161)
2014
2
Patients with polycythemia vera have worst impairment of quality of life among patients with newly diagnosed myeloproliferative neoplasms. (23398206)
2013
3
Polycythemia vera and the Jak2(V617F) mutation in a case of hereditary spherocytosis. (23588264)
2013
4
Epidemiology Of Myelfibrosis (Mf), Essential Thrombocythemia (Et), And Polycythemia Vera (Pv) In The European Union (Eu). (24372927)
2013
5
Severe chest and back pain and bilateral massive adrenal swelling in polycythemia vera: an uncommon case after esophagectomy. (22643542)
2012
6
Pulmonary artery pressure and iron deficiency in patients with upregulation of hypoxia sensing due to homozygous VHL(R200W) mutation (Chuvash polycythemia). (21993671)
2012
7
The importance of cytogenetics in polycythemia vera, primary myelofibrosis and essential thrombocythemia. (23049351)
2011
8
Increased serum levels of neutrophil gelatinase-associated lipocalin in patients with essential thrombocythemia and polycythemia vera. (21133718)
2011
9
The JAK2V617F allele burden and STAT3- and STAT5 phosphorylation in myeloproliferative neoplasms: early prefibrotic myelofibrosis compared with essential thrombocythemia, polycythemia vera and myelofibrosis. (21749449)
2011
10
Images in clinical medicine. Nonobstructive hydronephrosis with secondary polycythemia. (21732830)
2011
11
Polycythemia vera with pancytopenia and red cell fragmentation. (22167863)
2011
12
Polycythemia from mast cell activation syndrome: lessons learned. (21642812)
2011
13
Pruritic indurated plaques on the legs of a 62-year-old woman--quiz case. Polycythemia vera (PCV). (21242405)
2011
14
Effects of polycythemia on systemic endothelial function in chronic hypoxic lung disease. (21252221)
2011
15
Development of polycythemia vera after chemotherapy-induced remission of acute myeloid leukemia: a case report. (21454967)
2011
16
Subclinical hypercortisolism among polycythemia vera patients. (20606359)
2010
17
Strong association between polycythemia and glucose intolerance in elderly high-altitude dwellers in Asia. (20398132)
2010
18
Cerebral Venous Thrombosis and Venous Infarction: Case Report of a Rare Initial Presentation of Smoker's Polycythemia. (21151631)
2010
19
Postimatinib therapy emergence of a new JAK2V617F clone and subsequent development of overt polycythemia vera in a patient with chronic myelogenous leukaemia. (20408872)
2010
20
Polycythemia vera as a presentation of renal angiomyolipoma: a case report. (19946506)
2009
21
The 'GGCC' haplotype of JAK2 confers susceptibility to JAK2 exon 12 mutation-positive polycythemia vera. (19440215)
2009
22
Clonal heterogeneity in polycythemia vera patients with JAK2 exon12 and JAK2-V617F mutations. (18195094)
2008
23
Polycythemia as the first manifestation of Cushing's disease. (19092303)
2008
24
Pegylated interferon-alfa-2a induces complete hematologic and molecular responses with low toxicity in polycythemia vera. (18650451)
2008
25
Perspective: Osler's 1903 paper on polycythemia vera. (18552569)
2008
26
Polycythemia vera is not initiated by JAK2V617F mutation. (17198871)
2007
27
Anticoagulation after coronary artery surgery in patients with polycythemia vera: report of two cases. (17803581)
2007
28
Cutaneous mononuclear cells and eosinophils are significantly increased after warm water challenge in pruritic areas of polycythemia vera. (18001415)
2007
29
von Hippel-Lindau mutation in mice recapitulates Chuvash polycythemia via hypoxia-inducible factor-2alpha signaling and splenic erythropoiesis. (17992257)
2007
30
A phase II trial of tipifarnib in myelofibrosis: primary, post-polycythemia vera and post-essential thrombocythemia. (17581608)
2007
31
Different involvement of the megakaryocytic lineage by the JAK2 V617F mutation in Polycythemia vera, essential thrombocythemia and chronic idiopathic myelofibrosis. (17262192)
2007
32
Increased energy expenditure after dilutional exchange transfusion for neonatal polycythemia. (17914128)
2007
33
Bone marrow JAK2V617F allele burden and clinical correlates in polycythemia vera. (17476276)
2007
34
The JAK2 V617F mutation occurs in hematopoietic stem cells in polycythemia vera and predisposes toward erythroid differentiation. (16603627)
2006
35
Diffuse large B-cell lymphoma as a second, clonally unrelated lymphoproliferative disease in a patient with IgM monoclonal gammopathy of undetermined significance (MGUS) and concomitant polycythemia vera rubra. (16753887)
2006
36
Platelet-mediated erythromelalgic, cerebral, ocular and coronary microvascular ischemic and thrombotic manifestations in patients with essential thrombocythemia and polycythemia vera: a distinct aspirin-responsive and coumadin-resistant arterial thrombophilia. (17127481)
2006
37
Expression of Jak2V617F causes a polycythemia vera-like disease with associated myelofibrosis in a murine bone marrow transplant model. (16478879)
2006
38
Mutation of the prothrombin gene and thrombotic events in patients with polycythemia vera or essential thrombocythemia: a cohort study. (15749677)
2005
39
Polycythemia vera and idiopathic erythrocytosis: comparison of clinical and laboratory parameters. (15270182)
2004
40
Usefulness of the quantitative assessment of PRV-1 gene expression for the diagnosis of polycythemia vera and essential thrombocythemia patients. (14998918)
2004
41
The rate of progression to polycythemia vera or essential thrombocythemia in patients with erythrocytosis or thrombocytosis. (13679323)
2003
42
PRV-1 mRNA expression and other molecular markers in polycythemia rubra vera. (12901344)
2003
43
A case of erythropoietin-producing renal cell carcinoma with polycythemia]. (12402477)
2002
44
Genetic heterogeneity of primary familial and congenital polycythemia. (11559951)
2001
45
STAT3 is constitutively active in some patients with Polycythemia rubra vera. (11378264)
2001
46
Circulating erythroid progenitors in polycythemia vera are hypersensitive to insulin-like growth factor-1 in vitro: studies in an improved serum-free medium. (8274756)
1994
47
Morphometric study of the bone marrow in polycythemia vera following interferon-alpha therapy. (8516217)
1993
48
Tumor cells are the site of erythropoietin synthesis in human renal cancers associated with polycythemia. (2297568)
1990
49
POEMS syndrome associated with polycythemia vera. (2537136)
1989
50
Polycythemia with papilledema and infratentorial vascular tumors. (13534215)
1958

Genetic Variations for Polycythemia

Expression for genes affiliated with Polycythemia

Sources:
1BioGPS, 15Gene Expression Omnibus DataSets
See all sources
Expression patterns in normal tissues for genes affiliated with Polycythemia

Search GEO for disease gene expression data for Polycythemia.

Pathways for genes affiliated with Polycythemia

Sources:
52QIAGEN, 30KEGG, 54Reactome, 38NCBI BioSystems Database, 12EMD Millipore, 4Cell Signaling Technology, 53R&D Systems
See all sources

Pathways related to Polycythemia according to GeneCards/GeneDecks:

(show top 50)    (show all 56)
idSuper pathways (with members indented)ScoreTop Affiliating Genes
1
Hide members
10.8PPBP, JAK2, STAT5A, ITGB3, IL3, TIMP1
210.8JAK2, PTPN6, IL3, EPO, IFNA2, MPL
3
Hide members
10.8PPBP, THPO, TIMP1, JAK2, STAT5A, ITGB3
4
Hide members
10.8THPO, TIMP1, ITGB3, STAT5A, EPOR, JAK2
5
Hide members
10.8IFNA2, PPBP, TIMP1, JAK2, ITGB3, MPL
6
Hide members
10.8STAT5A, MPL, EPOR, IL3, JAK2, PPBP
7
Hide members
10.8PTPN6, IL3, TIMP1, PPBP, JAK2, KITLG
810.7IFNA2, KITLG, IL3, EPOR, EPO, ITGB3
9
Hide members
10.7PPBP, ITGB3, TIMP1, EPOR, IL3, THPO
1010.7THPO, ITGB3, EPO, EPOR, IL3, KITLG
11
Hide members
10.7EPO, STAT5A, JAK2, EPOR, PTPN6, ITGB3
12
Hide members
10.7PTPN6, JAK2, KITLG, EPOR, STAT5A, EPO
13
Development EPO-induced Jak-STAT pathway
Hide members
10.7EPOR, STAT5A, JAK2, SOCS3, EPO, PTPN6
14
Development Thrombopoetin signaling via JAK-STAT pathway
Hide members
10.7STAT5A, MPL, JAK2, SOCS3, PTPN6, THPO
15
Hide members
10.7IL3, TIMP1, EPOR, THPO, KITLG, PPBP
16
Hide members
10.7EPOR, PPBP, TIMP1, IL3, THPO, KITLG
17
Hide members
10.7THPO, KITLG, IL3, PPBP, TIMP1, EPOR
18
Hide members
10.7TIMP1, PPBP, IL3, KITLG, THPO, ITGB3
19
Hide members
10.7MPL, SOCS3, TIMP1, ITGB3, THPO, PPBP
20
Hide members
10.7PTPN6, IL3, STAT5A, JAK2, IFNA2, SOCS3
21
Hide members
10.7KITLG, JAK2, ITGB3, EPOR, EPO
22
Hide members
10.7THPO, KITLG, IL3, JAK2, PPBP
23
Hide members
10.7THPO, MPL, STAT5A, JAK2, SOCS3
2410.7JAK2, STAT5A, ITGB3, SOCS3, PTPN6
2510.7SOCS3, STAT5A, JAK2, IL3, PTPN6
26
Hide members
10.7JAK2, STAT5A, PTPN6, IL3, SOCS3
27
Immune response IL-2 activation and signaling pathway
Hide members
10.7SOCS3, JAK2, STAT5A, IL3, PTPN6
28
Hide members
10.6JAK2, KITLG, PTPN6, STAT5A
2910.6STAT5A, PTPN6, JAK2, SOCS3
3010.6SOCS3, JAK2, STAT5A, PTPN6
31
Hide members
10.6JAK2, SOCS3, STAT5A, PTPN6
3210.6JAK2, STAT5A, ITGB3, SOCS3
33
Hide members
10.6THPO, KITLG, PPBP, TIMP1
34
Development PDGF signaling via STATs and NF-kB
Hide members
10.6TIMP1, SOCS3, JAK2, STAT5A
35
Immune response Oncostatin M signaling via JAK-Stat in human cells
Hide members
10.6JAK2, SOCS3, TIMP1, STAT5A
36
Hide members
10.6PF4, STAT5A, JAK2, PPBP
37
Hide members
10.6ITGB3, PF4, PPBP, TIMP1
3810.6JAK2, EPO, EPOR
39
Hide members
10.6MPL, THPO, ITGB3
4010.6PTPN6, SOCS3, JAK2
4110.6PTPN6, STAT5A, JAK2
4210.6PTPN6, STAT5A, JAK2
4310.6ITGB3, PTPN6, VHL
4410.6TIMP1, SOCS3, JAK2
45
Development Leptin signaling via JAK/STAT and MAPK cascades
Hide members
10.6SOCS3, TIMP1, JAK2
4610.6TIMP1, ITGB3, VHL
4710.6JAK2, SOCS3, IFNA2
4810.6SOCS3, JAK2, STAT5A
4910.6STAT5A, SOCS3, JAK2
50
Immune response IFN alpha/beta signaling pathway
Hide members
10.6IFNA2, SOCS3, PTPN6

Compounds for genes affiliated with Polycythemia

Sources:
45Novoseek, 24HMDB, 50PharmGKB, 29IUPHAR, 11DrugBank, 60Tocris Bioscience, 2BitterDB
See all sources

Compounds related to Polycythemia according to GeneCards/GeneDecks:

(show top 50)    (show all 157)
idCompoundScoreTop Affiliating Genes
1tyrosine4511.6EPOR, PF4, IL3, KITLG, THPO, ACP1
2vegf4511.4PTPN6, ACP1, THPO, TIMP1, VHL, IFNA2
3phosphatidylinositol4511.4KITLG, IL3, EPOR, EPO, MPL, STAT5A
4alanine4511.4PTPN6, TIMP1, IFNA2, ACP1, THPO, KITLG
5cysteine4511.4EPOR, PF4, IL3, THPO, ACP1, PTPN6
6gp 1304511.3TIMP1, PTPN6, THPO, KITLG, IL3, EPOR
7thymidine45 2412.3PPBP, IFNA2, JAK2, STAT5A, EPOR, PF4
8agar4511.3JAK2, STAT5A, G6PD, EPOR, PF4, IL3
9ly2940024511.3EPO, THPO, IL3, KITLG, ACP1, EPOR
105-aza-2deoxycytidine4511.2EPO, JAK2, TIMP1, VHL, SOCS3, IL3
11aspirin45 50 29 2414.2ITGB3, G6PD, PF4, TIMP1, PPBP, KITLG
12rapamycin4511.2STAT5A, EPO, IL3, THPO, ACP1, JAK2
13hydroxyurea45 50 1113.2THPO, PF4, EPO, KITLG, JAK2, PPBP
14nitric oxide45 11 2413.2PTPN6, TIMP1, VHL, KITLG, EPOR, STAT5A
15serine4511.2MPL, EPOR, PTPN6, JAK2, G6PD, TIMP1
16lysine4511.2VHL, JAK2, IFNA2, SOCS3, ITGB3, MPL
17cisplatin45 50 60 1114.2ACP1, IFNA2, G6PD, JAK2, EPO, TIMP1
18lipid4511.2STAT5A, JAK2, PPBP, G6PD, IFNA2, PF4
19anagrelide45 1112.1PF4, EPO, MPL, JAK2, IFNA2, THPO
20oxygen45 2412.1PF4, EPOR, VHL, STAT5A, EPO, JAK2
21epinephrine45 11 2413.1ACP1, THPO, IFNA2, G6PD, KITLG, PF4
22cytarabine45 50 1113.1THPO, EPO, IL3, IFNA2, STAT5A, KITLG
23wortmannin4511.1IL3, KITLG, PF4, EPOR, JAK2, STAT5A
24actinomycin d4511.1TIMP1, VHL, G6PD, JAK2, IL3, THPO
25glucose4511.1SOCS3, IFNA2, KITLG, PPBP, PTPN6, PF4
26methylcellulose4511.1KITLG, TIMP1, IL3, EPOR, EPO, THPO
27herbimycin a45 6012.1JAK2, IL3, KITLG, ACP1, PTPN6, TIMP1
28genistein45 29 60 2 11 2416.1IL3, ACP1, THPO, KITLG, STAT5A, JAK2
29ribavirin45 50 1113.1IFNA2, SOCS3, G6PD, EPO, IL3, TIMP1
30pixy3214511.1IL3, KITLG, THPO, TIMP1, EPO
31iron45 2412.1KITLG, THPO, VHL, IFNA2, ITGB3, MPL
32filgrastim45 1112.0THPO, EPO, IL3, KITLG, IFNA2
33polyethylene glycol4511.0THPO, IFNA2, PF4, MPL, G6PD, KITLG
34lactate4511.0TIMP1, THPO, KITLG, IL3, PF4, G6PD
35aspartate4511.0JAK2, G6PD, STAT5A, ACP1, PTPN6
36phosphotyrosine4511.0SOCS3, JAK2, PTPN6, ACP1, IL3, EPOR
37etoposide45 50 60 1114.0TIMP1, ACP1, THPO, IL3, PF4, STAT5A
38estrogen4511.0THPO
39imatinib45 50 1112.9IL3, EPO, STAT5A, JAK2, KITLG, THPO
40gm-csf45 2911.9STAT5A, THPO
41histamine45 29 2412.9TIMP1, KITLG, IL3, THPO, PF4, PPBP
42amifostine45 1111.8KITLG, EPO, THPO, IL3
43h2o24510.8G6PD, PTPN6, THPO, KITLG, IL3, JAK2
44prostacyclin4510.8ACP1, PPBP, THPO, IL3, TIMP1, PF4
45butyrate4510.8JAK2, THPO, ACP1
46indomethacin45 60 29 1113.8PF4, ACP1
47cyclosporin a45 29 6012.7JAK2, ACP1, TIMP1, KITLG, IL3, EPO
48retinoic acid45 2411.7TIMP1, IFNA2, ACP1, PTPN6, STAT5A, IL3
49carboplatin45 50 1112.7THPO, IFNA2, IL3, EPO, KITLG
505fluorouracil4510.4MPL, PF4, IL3, IFNA2, KITLG, THPO

GO Terms for genes affiliated with Polycythemia

Sources:
16Gene Ontology
See all sources

Cellular components related to Polycythemia according to GeneCards/GeneDecks:

idNameGO IDScoreTop Affiliating Genes
1extracellular spaceGO:00561510.6THPO, IFNA2, PPBP, EPO, PF4, IL3
2platelet alpha granule lumenGO:03109310.6PF4, PPBP, TIMP1
3extracellular regionGO:00557610.5TIMP1, IFNA2, PPBP, EPO, EPOR, PF4

Biological processes related to Polycythemia according to GeneCards/GeneDecks:

(show all 20)
idNameGO IDScoreTop Affiliating Genes
1blood coagulationGO:00759611.2PTPN6, TIMP1, IFNA2, PPBP, JAK2, ITGB3
2platelet activationGO:03016811.0TIMP1, PPBP, ITGB3, MPL, PF4, THPO
3JAK-STAT cascade involved in growth hormone signaling pathwayGO:06039710.9SOCS3, JAK2, STAT5A, PTPN6
4positive regulation of peptidyl-tyrosine phosphorylationGO:05073110.9JAK2, ITGB3, IL3, KITLG
5cytokine-mediated signaling pathwayGO:01922110.9IFNA2, SOCS3, JAK2, PF4, PTPN6
6erythrocyte maturationGO:04324910.9EPO, G6PD, TIMP1
7regulation of interferon-gamma-mediated signaling pathwayGO:06033410.9SOCS3, JAK2, PTPN6
8platelet degranulationGO:00257610.9PF4, ITGB3, PPBP, TIMP1
9positive regulation of tyrosine phosphorylation of Stat5 proteinGO:04252310.9JAK2, EPO, IL3
10positive regulation of cell differentiationGO:04559710.8JAK2, SOCS3, VHL
11JAK-STAT cascadeGO:00725910.8STAT5A, JAK2, SOCS3
12regulation of type I interferon-mediated signaling pathwayGO:06033810.8IFNA2, SOCS3, PTPN6
13positive regulation of cell proliferationGO:00828410.7PTPN6, IL3, EPO, JAK2, TIMP1
14negative regulation of mast cell apoptotic processGO:03302610.7KITLG, STAT5A
15positive regulation of DNA replicationGO:04574010.7EPO, IL3, KITLG
16positive regulation of mast cell proliferationGO:07066810.7KITLG, STAT5A
17peptidyl-tyrosine phosphorylationGO:01810810.6JAK2, STAT5A, PTPN6
18type I interferon-mediated signaling pathwayGO:06033710.6PTPN6, SOCS3, IFNA2
19mammary gland epithelium developmentGO:06118010.4STAT5A, JAK2
20interferon-gamma-mediated signaling pathwayGO:06033310.3PTPN6, JAK2, SOCS3

Molecular functions related to Polycythemia according to GeneCards/GeneDecks:

idNameGO IDScoreTop Affiliating Genes
1protein bindingGO:00551510.9VHL, IFNA2, SOCS3, G6PD, JAK2, STAT5A
2growth factor activityGO:00808310.5THPO, KITLG, IL3, PPBP
3cytokine activityGO:00512510.3IFNA2, IL3, KITLG, THPO

Products for genes affiliated with Polycythemia

  • Antibodies
  • Proteins
  • Lysates
  • Antibodies

Sources for Polycythemia

3CDC
13ExPASy
14FMA
22GTR
23HGMD
24HMDB
25ICD10
26ICD10 via Orphanet
27ICD9CM
29IUPHAR
30KEGG
35MeSH
36MESH via Orphanet
37MGI
40NCIt
41NDF-RT
44NINDS
45Novoseek
47OMIM
48OMIM via Orphanet
51PubMed
52QIAGEN
58SNOMED-CT via Orphanet
61UMLS
62UMLS via Orphanet